Publications

  1. Hasin T, Huebner M, Li Z, Brown D, Stulak JM, Boilson BA, Joyce L, Pereira NL, Kushwaha SS, Park SJ. Association of HeartMate II Left Ventricular Assist Device Flow Estimate with Thermodilution Cardiac Output. ASAIO J. 2014 Sep-Oct; 60(5):513-8.
    View PubMed
  2. Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL. The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation. 2014 Jul 27; 98(2):229-38.
    View PubMed
  3. Alsara O, Reeves RK, Pyfferoen MD, Trenary TL, Engen DJ, Vitse ML, Kessler SM, Kushwaha SS, Clavell AL, Thomas RJ, Lopez-Jimenez F, Park SJ, Perez-Terzic CM. Inpatient Rehabilitation Outcomes for Patients Receiving Left Ventricular Assist Device. Am J Phys Med Rehabil. 2014 Jun 04.
    View PubMed
  4. Witt CM, Fenstad ER, Cha YM, Kane GC, Kushwaha SS, Hodge DO, Asirvatham SJ, Oh JK, Packer DL, Powell BD. Increase in pulmonary arterial pressure after atrial fibrillation ablation: incidence and associated findings. J Interv Card Electrophysiol. 2014 Jun; 40(1):47-52. Epub 2014 Feb 16.
    View PubMed
  5. Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ, HeartMate II Clinical Investigators. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2014 May 6; 63(17):1751-7. Epub 2014 Mar 05.
    View PubMed
  6. Dunlay SM, Pereira NL, Kushwaha SS. Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc. 2014 May; 89(5):662-76. Epub 2014 Mar 29.
    View PubMed
  7. Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, Roger VL, Kushwaha SS. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014 Apr; 33(4):359-65. Epub 2013 Dec 27.
    View PubMed
  8. Deo SV, Sung K, Daly RC, Shah IK, Altarabsheh SE, Stulak JM, Joyce LD, Boilson BA, Kushwaha SS, Park SJ. Cardiac transplantation after bridged therapy with continuous flow left ventricular assist devices. Heart Lung Circ. 2014 Mar; 23(3):224-8. Epub 2013 Aug 13.
    View PubMed
  9. Hasin T, Deo S, Maleszewski JJ, Topilsky Y, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Kushwaha SS, Park SJ. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014 Jan-Feb; 60(1):9-14.
    View PubMed
  10. Deo SV, Sung K, Daly RC, Shah IK, Altarabsheh SE, Stulak JM, Joyce LD, Boilson BA, Kushwaha SS, Park SJ. Cardiac transplantation after bridged therapy with continuous flow left ventricular assist devices. Heart Lung Circ. 2014; 23(3):224-8.
  11. Guddeti RR, Matsuo Y, Matsuzawa Y, Aoki T, Lennon RJ, Lerman LO, Kushwaha SS, Lerman A. Ischemic Cardiomyopathy is Associated With Coronary Plaque Progression and Higher Event Rate in Patients After Cardiac Transplantation. J Am Heart Assoc. 2014; 3(4). Epub 2014 Aug 05.
    View PubMed
  12. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013 Dec 3; 62(22):2046-72. Epub 2013 Nov 18.
    View PubMed
  13. Liang JJ, Geske JR, Boilson BA, Frantz RP, Edwards BS, Kushwaha SS, Kremers WK, Weinshilboum RM, Pereira NL. TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation. Pharmacogenet Genomics. 2013 Dec; 23(12):658-65.
    View PubMed
  14. Loar RW, Driscoll DJ, Kushwaha SS, Cramer CH, O'Leary PW, Daly RC, Mauriello DA, Johnson JN. Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients. Pediatr Transplant. 2013 Dec; 17(8):794-9. Epub 2013 Oct 06.
    View PubMed
  15. Fine NM, Topilsky Y, Oh JK, Hasin T, Kushwaha SS, Daly RC, Joyce LD, Stulak JM, Pereira NL, Boilson BA, Clavell AL, Edwards BS, Park SJ. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013 Nov; 6(11):1129-40. Epub 2013 Oct 02.
    View PubMed
  16. Matsuo Y, Cassar A, Li J, Flammer AJ, Choi BJ, Herrmann J, Gulati R, Lennon RJ, Kang SJ, Maehara A, Kitabata H, Akasaka T, Lerman LO, Kushwaha SS, Lerman A. Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy. Eur Heart J. 2013 Oct; 34(37):2905-15. Epub 2013 Jun 19.
    View PubMed
  17. Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Cerhan JR, Roger VL. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013 Sep 3; 62(10):881-6. Epub 2013 Jun 27.
    View PubMed
  18. Cassar A, Matsuo Y, Herrmann J, Li J, Lennon RJ, Gulati R, Lerman LO, Kushwaha SS, Lerman A. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J. 2013 Sep; 34(33):2610-7. Epub 2013 Jun 25.
    View PubMed
  19. Matsuo Y, Cassar A, Yoshino S, Flammer AJ, Li J, Gulati R, Topilsky Y, Raichlin E, Lennon RJ, Lerman LO, Rihal CS, Kushwaha SS, Lerman A. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. J Heart Lung Transplant. 2013 Aug; 32(8):784-91.
    View PubMed
  20. Noheria A, Patel SM, Mirzoyev S, Madhavan M, Friedman PA, Packer DL, Daly RC, Kushwaha SS, Edwards BS, Asirvatham SJ. Decreased postoperative atrial fibrillation following cardiac transplantation: the significance of autonomic denervation. Pacing Clin Electrophysiol. 2013 Jun; 36(6):741-7. Epub 2013 Feb 25.
    View PubMed
  21. Misiri J, DeSimone CV, Park SJ, Kushwaha SS, Friedman PA, Bruce CJ, Asirvatham SJ. Novel nonsurgical left ventricular assist device and system. Cardiovasc Revasc Med. 2013 May-Jun; 14(3):154-6. Epub 2013 May 08.
    View PubMed
  22. Swiecicki PL, Edwards BS, Kushwaha SS, Dispenzieri A, Park SJ, Gertz MA. Left ventricular device implantation for advanced cardiac amyloidosis. J Heart Lung Transplant. 2013 May; 32(5):563-8. Epub 2013 Mar 06.
    View PubMed
  23. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  24. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95(2):389-96.
    View PubMed
  25. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15; 61(2):153-63. Epub 2012 Dec 05.
    View PubMed
  26. Hardegree EL, Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Kushwaha SS, Hsiao JF, McCully RB, Oh JK, Pellikka PA, Kane GC. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol. 2013 Jan 1; 111(1):143-8. Epub 2012 Oct 23.
    View PubMed
  27. Bishu K, Ogut O, Kushwaha S, Mohammed SF, Ohtani T, Xu X, Brozovich FV, Redfield MM. Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with Angiotensin receptor blockade. PLoS One. 2013; 8(12):e81325. Epub 2013 Dec 03.
    View PubMed
  28. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the world heart federation. Global Heart. 2013; 8(4):355-82.
  29. Hasin T, Topilsky Y, Kremers WK, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Stulak JM, Kushwaha SS, Park SJ, Pereira NL. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012 Nov 1; 110(9):1322-8. Epub 2012 Jul 21.
    View PubMed
  30. Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant. 2012 Sep; 12(9):2487-97. Epub 2012 Jul 09.
    View PubMed
  31. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012 Feb 7; 125(5):708-20. Epub 2011 Dec 29.
    View PubMed
  32. Kushwaha S, Xu X. Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies. Trends Cardiovasc Med. 2012 Feb; 22(2):39-43. Epub 2012 Jul 28.
    View PubMed
  33. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan 3; 59(1):26-36.
    View PubMed
  34. Park SJ, Kushwaha SS, McGregor CG. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy. Clin Pharmacol Ther. 2012 Jan; 91(1):94-100. Epub 2011 Nov 23.
    View PubMed
  35. Hasin T, Kushwaha S. Reply. J Am Coll Cardiol. 2012; 59(24):2220.
  36. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  37. Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging. 2011 Nov; 4(6):648-61. Epub 2011 Sep 21.
    View PubMed
  38. Raichlin E, Al-Omari MA, Hayes CL, Edwards BS, Frantz RP, Boilson BA, Clavell AL, Rodeheffer RJ, Schirger JA, Kushwaha SS, Allison TG, Pereira NL. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant. 2011 Oct; 30(10):1153-60. Epub 2011 May 31.
    View PubMed
  39. Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, Sivasubbu S, Lin X, Ekker S, Xu X. Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res. 2011 Sep 2; 109(6):658-69. Epub 2011 Jul 14.
    View PubMed
  40. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  41. Khalpey Z, Miller DV, Schmitto JD, Kushwaha SS. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin. Transplant Proc. 2011 Jun; 43(5):1893-9.
    View PubMed
  42. Friedman PA, Kushwaha SS, Bruce CJ, Park SJ, Ladewig DJ, Mikell SB, Johnson SB, Suddendorf SH, Danielsen AJ, Asirvatham SJ. Use of the aortoatrial continuity as means of providing left ventricular assist support without entering the ventricle: a feasibility study. J Card Fail. 2011 Jun; 17(6):511-8. Epub 2011 Mar 25.
    View PubMed
  43. Saleh HK, Villarraga HR, Kane GC, Pereira NL, Raichlin E, Yu Y, Koshino Y, Kushwaha SS, Miller FA Jr, Oh JK, Pellikka PA. Normal left ventricular mechanical function and synchrony values by speckle-tracking echocardiography in the transplanted heart with normal ejection fraction. J Heart Lung Transplant. 2011 Jun; 30(6):652-8. Epub 2010 Dec 30.
    View PubMed
  44. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011 May; 4(3):266-75. Epub 2011 Feb 08.
    View PubMed
  45. Gharacholou SM, Maleszewski JJ, Borlaug BA, Cosio FG, Dearani JA, Kushwaha SS, Ammash NM. "Carcinoid-like" tricuspid valvulopathy associated with nephrogenic systemic fibrosis. Echocardiography. 2011 Mar; 28(3):E46-9. Epub 2011 Mar 03.
    View PubMed
  46. Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011 Mar; 4(3):211-22.
    View PubMed
  47. Topilsky Y, Oh JK, Atchison FW, Shah DK, Bichara VM, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr. 2011 Feb; 24(2):157-69.
    View PubMed
  48. Pereira NL, Chen D, Kushwaha SS, Park SJ. Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2010 Oct; 11(4):503-5. Epub 2010 Jul 16.
    View PubMed
  49. Pereira NL, Park SJ, Daly RC, Kushwaha SS, Edwards WD. De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant. Ann Thorac Surg. 2010 Oct; 90(4):1345-7.
    View PubMed
  50. Boilson BA, Raichlin E, Park SJ, Kushwaha SS. Device therapy and cardiac transplantation for end-stage heart failure. Curr Probl Cardiol. 2010 Jan; 35(1):8-64.
    View PubMed
  51. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88(2):219-25.
    View PubMed
  52. Raichlin E, Prasad A, Kremers WK, Edwards BS, Rihal CS, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J. 2009 Jun; 30(11):1356-63. Epub 2009 Apr 21.
    View PubMed
  53. Raichlin E, Kushwaha SS, Lennon RJ, Frantz RP, Edwards BS, Prasad A, Rihal CS, Lerman A. Features of cardiac allograft coronary endothelial dysfunction. Am J Cardiol. 2009 Apr 15; 103(8):1154-8. Epub 2009 Feb 28.
    View PubMed
  54. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009 Apr 14; 53(15):1279-86.
    View PubMed
  55. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009 Apr; 28(4):320-7.
    View PubMed
  56. van de Beek D, Kremers WK, Kushwaha SS, McGregor CG, Wijdicks EF. No major neurologic complications with sirolimus use in heart transplant recipients. Mayo Clin Proc. 2009 Apr; 84(4):330-2.
    View PubMed
  57. Raichlin E, Villarraga HR, Chandrasekaran K, Clavell AL, Frantz RP, Kushwaha SS, Rodeheffer RJ, McGregor CG, Daly RC, Park SJ, Kremers WK, Edwards BS, Pereira NL. Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant. 2009 Jan; 9(1):132-9. Epub 2008 Nov 27.
    View PubMed
  58. Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, Pereira NL, Rodeheffer RJ, Daly RC, McGregor CG, Edwards BS, Kushwaha SS. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008 Nov 27; 86(10):1395-400.
    View PubMed
  59. Kushwaha SS, Raichlin E, Sheinin Y, Kremers WK, Chandrasekaran K, Brunn GJ, Platt JL. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J. 2008 Nov; 29(22):2742-50. Epub 2008 Sep 11.
    View PubMed
  60. Raichlin E, Kushwaha SS. Proliferation signal inhibitors and cardiac allograft vasculopathy. Curr Opin Organ Transplant. 2008 Oct; 13(5):543-50.
    View PubMed
  61. Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Kyle RA, Rajkumar SV, Edwards BS, Rodeheffer RJ, Frantz RP, Kushwaha SS, Clavell AL, Dearani JA, Sundt TM, Daly RC, McGregor CG, Gastineau DA, Litzow MR, Gertz MA. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant. 2008 Aug; 27(8):823-9. Epub 2008 Jul 03.
    View PubMed
  62. Khalpey Z, Kushwaha SS. 'Rapping' up cardiac allograft vasculopathy. Clin Cardiol. 2008 Jun; 31(6):286-7.
    View PubMed
  63. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007 Dec 4; 116(23):2726-33. Epub 2007 Nov 19.
    View PubMed
  64. Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation. 2007 Aug 27; 84(4):467-74.
    View PubMed
  65. Raichlin ER, McConnell JP, Lerman A, Kremers WK, Edwards BS, Kushwaha SS, Clavell AL, Rodeheffer RJ, Frantz RP. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant. 2007 Aug; 26(8):826-33.
    View PubMed
  66. Puri A, McGoon MD, Kushwaha SS. Pulmonary arterial hypertension: current therapeutic strategies. Nat Clin Pract Cardiovasc Med. 2007 Jun; 4(6):319-29.
    View PubMed
  67. Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A, Holmes DR Jr, Lerman A. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006 Oct 27; 82(8):1108-11.
    View PubMed
  68. Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant. 2006 Jan; 25(1):53-60. Epub 2005 Nov 02.
    View PubMed
  69. Miller WL, Edwards BS, Kremers WK, Kushwaha SS, McGregor CGA, Daly RC, Jaffe AS. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant. 2005 Dec; 24(12):2075-8.
    View PubMed
  70. Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant. 2005 Dec; 24(12):2129-36.
    View PubMed
  71. Kushwaha SS. Cardiac structure and function. J Am Coll Cardiol. 2004 Jul 21; 44(2 Suppl S):2A-6A.
    View PubMed
  72. Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, Kushwaha SS, Caplice NM. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation. 2003 Jul 15; 108(2):143-9. Epub 2003 Jun 30.
    View PubMed
  73. Mayer DF, Kushwaha SS. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases. Curr Opin Rheumatol. 2003 May; 15(3):219-25.
    View PubMed
  74. Squires RW, Leung TC, Cyr NS, Allison TG, Johnson BD, Ballman KV, Wagner JA, Olson LJ, Frantz RP, Edwards BS, Kushwaha SS, Dearani JA, Daly RC, McGregor CG, Rodeheffer RJ. Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc. 2002 Dec; 77(12):1295-300.
    View PubMed
  75. Krishnan SC, Falsone JM, Sanders WE, Chen H, Mill MR, Kushwaha SS. Catheter ablation of atrial flutter in a heart transplant recipient. Pacing Clin Electrophysiol. 2002 Aug; 25(8):1262-5.
    View PubMed
  76. Baran DA, Segura L, Kushwaha S, Courtney M, Correa R, Fallon JT, Cheng J, Lansman SL, Gass AL. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. J Heart Lung Transplant. 2001 Jan; 20(1):59-70.
    View PubMed
  77. Kushwaha SS, Ambrose JA. Does ischemic preconditioning limit infarct size in non-Q-wave myocardial infarction? Coron Artery Dis. 2000 Mar; 11(2):191-4.
    View PubMed
  78. Alexis JD, Nayak HM, Kushwaha SS, Lansman SL, Mehta D, Gass AL. New preexcitation following cardiac transplant. Int J Cardiol. 1998 Jun 1; 65(1):71-4.
    View PubMed
  79. Alexis JD, Lao CD, Selter JG, Courtney MC, Correa DK, Lansman SL, Kushwaha SS, Gass AL. Cardiac troponin T: a noninvasive marker for heart transplant rejection? J Heart Lung Transplant. 1998 Apr; 17(4):395-8.
    View PubMed
  80. Kushwaha SS, Narula J, Narula X, Zervos G, Semigran S, Fischman A, Alpert N, Dec GW, Gewirtz H. Natural history of changes in myocardial blood flow and microvascular dilator capacity in humans following orthotopic cardiac transplantation: observations in patients with normally functioning allografts. Am J Cardiol. 1998; 82:1377-81.
    View PubMed
  81. Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol. 1997 Aug; 30(2):533-8.
    View PubMed
  82. Kushwaha SS, Fallon JT, Fuster V. Medical Progress: Restrictive Cardiomyopathy. N Engl J Med. 1997; 336:267-76.
    View PubMed
  83. Kushwaha SS, Bustami M, Tadjkarimi S, Ilsley CD, Mitchell AG, Yacoub MH. Late endothelial function of free and pedicled internal mammary artery grafts. J Thorac Cardiovasc Surg. 1995 Aug; 110(2):453-62.
    View PubMed
  84. Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA, et al. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994 Apr; 107(4):1146-53.
    View PubMed
  85. Kushwaha SS, Bustami M, Lythall DA, Barbir M, Mitchell AG, Yacoub MH. Coronary endothelial function in cardiac transplant recipients with accelerated coronary disease. Coron Artery Dis. 1994 Feb; 5(2):147-54.
    View PubMed
  86. Kushwaha S, Banner N, Patel N, Cox A, Patton H, Yacoub M. The effect of beta blockade on the cardiopulmonary and neurohumoral response to dynamic exercise in cardiac transplant recipients. Br Heart J. 1994; 71:431-6.
    View PubMed
  87. Kushwaha S, Fuster V. The need for coronary surgery. Annual of Cardiac Surgery pp 95-13 Current Science London. 1994.
  88. Kushwaha S, Fuster V. The need for coronary surgery in 1993. Current Opinion in Cardiology. 1993; 8:889-96.
    View PubMed
  89. Lythall DA, Gibson DG, Kushwaha SS, Norell MS, Mitchell AG, Ilsley CJ. Changes in myocardial echo amplitude during reversible ischaemia in humans. Br Heart J. 1992 May; 67(5):368-76.
    View PubMed
  90. Rechavia E, Araujo LI, De Silva R, Kushwaha SS, Lammertsma AA, Jones T, Mitchell A, Maseri A, Yacoub MH. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1992 Jan; 19(1):100-6.
    View PubMed
  91. Norell M, Lythall D, Coghlan G, Cheng A, Kushwaha S, Swan J, Ilsley C, Mitchell A. Limited value of the resting electrocardiogram in assessing patients with recent onset chest pain: lessons from a chest pain clinic. Br Heart J. 1992; 67:53-6.
    View PubMed
  92. Kushwaha SS, Steinberg VL. Cauda equina syndrome in ankylosing spondylitis in a female. Postgrad Med J. 1992; 68:485-6.
    View PubMed
  93. Barbir M, Kushwaha S, Hunt B, Macken A, Thompson GR, Mitchell A, Robinson D, Yacoub M. Lipoprotein (a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet. 1992; 340:1500-2.
    View PubMed
  94. Barbir M, Hunt B, Kushwaha S, Kehely A, Prescot R, Thompson GR, Mitchell A, Yacoub M. Maxepa versus Bezafibrate in hyperlipidemic cardiac transplant recipients. Am J Cardiol. 1992; 70:1596-601.
    View PubMed
  95. Lythall DA, Logan-Sinclair RB, Ilsley CJ, Kushwaha SS, Yacoub MH, Gibson DG. Relation between cyclic variation in echo amplitude and segmental contraction in normal and abnormal hearts. Br Heart J. 1991 Oct; 66(4):268-76.
    View PubMed
  96. Kushwaha SS, Crossman DC, Bustami M, Davies GJ, Mitchell AG, Maseri A, Yacoub MH. Substance P for evaluation of coronary endothelial function after cardiac transplantation. J Am Coll Cardiol. 1991 Jun; 17(7):1537-44.
    View PubMed
  97. Kushwaha SS, Lythall DL, Maseri A, Mitchell AG, Yacoub MH. Coronary reactivity to ergonovine - possible relationship to accelerated coronary arterial disease in cardiac transplant recipients. European Heart Journal. 1991; 12:520-5.
    View PubMed
  98. O'Neil GS, Chester AH, Kushwaha S, Rose M, Tadijkarimi S, Yacoub M. Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries. Br Heart J. 1991; 66:212-6.
    View PubMed
  99. Barbir M, Rose M, Kushwaha S, Akl S, Mitchell A, Yacoub M. Low-dose simvastatin for the treatment of hypercholesterolemia in recipients of cardiac transplantation. Int J Cardiol. 1991; 33:241-6.
    View PubMed
  100. Akasaka T, Lythall DA, Kushwaha SS, Yoshida K, Yoshikawa J, Yacoub MH. Valvular regurgitation in heart-lung transplant recipients: a Doppler color flow study. J Am Coll Cardiol 1 1990 Mar; 15(3):576-81.
  101. Kushwaha SS, Jepson EM. Resolution of right atrial thrombus following anticoagulation. Int J Cardiol. 1990; 27:269-71.
    View PubMed
  102. Kushwaha SS, Mitchell AG, Yacoub MH. Coronary artery spasm after cardiac transplantation. AM J Cardiol. 1990; 65:1515-8.
    View PubMed
  103. Kibbler CC, Cohen DL, Cruicshank JK, Kushwaha SS, Morgan MY, Dick RD. Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm. Gut. 1985 Jul; 26(7):752-6.
    View PubMed